MI-ONESTREAM-SOFTWARE
29.3.2021 12:02:05 CEST | Business Wire | Press release
OneStream Software , a leading provider of modern corporate performance management (CPM) solutions for mid-sized to large enterprises, has been recognized as a market leader in the Business Application Research Center’s (BARC) global report on financial performance management software solutions. The BARC Score Financial Performance Management Global 2021 report places OneStream as a market leader with among the highest Portfolio Capabilities scores across vendors.
After hiring more than 270 employees throughout 2020, the company exceeded its 2020 projections and achieved 85 percent growth in Annual Recurring Revenue (ARR), accumulating more than 650 customers and achieving triple digit ARR CAGR in the EMEA region from 2017-2020. OneStream closed the year with 690 employees across 15 countries and more than 200 partners worldwide including PWC, Accenture and other general advisory firms. OneStream will continue to expand its workforce and partner ecosystem in 2021, including its opening of an Asia-Pacific (APAC) headquarters in Sydney, Australia.
“For OneStream to be recognized as a market leader in only the second year of coverage in the BARC Score report for Financial Performance Management solutions for global vendors reflects the broad capabilities of the platform and strong market adoption for global organizations worldwide. OneStream’s growth trajectory and commitment to 100% customer success positions the company to continue to challenge more established vendors as a leader in this market,” said Dr. Christian Fuchs, Senior Vice-President and Head of Data & Analytics Research at BARC.
The BARC Score report noted OneStream’s unified CPM platform for financial consolidation, close reporting and planning with built-in financial analytic engine and financial data quality capabilities as a strength, along with integrated analysis and reporting functionality. BARC also identified the OneStream MarketPlace, which hosts more than 50 downloadable business and productivity solutions optimized for the platform, as another strength. Overall, the report cited OneStream as having “excellent customer feedback for many important KPIs in BARC’s Planning Survey.”
“We are proud to be recognized in the BARC Score Financial Performance Management Global report as a market leader,” said Ricardo Rasche, Senior Vice President of International Sales for OneStream Software. “The BARC Score validates our underlying commitment to delivering 100% customer success for global organizations based in Germany, Austria, Switzerland and across the world. We are honored by this distinction as a market leader among much more established legacy vendors in EMEA.”
Last year in BARC’s The Planning Survey 20 , OneStream earned 38 top ranks and a 97% customer recommendation score. The BARC Score Financial Performance Management Global report examines global vendors, evaluating different criteria on two axes, “Portfolio Capabilities” and “Market Execution.” Vendors evaluated generated more than 20 million EUR in license revenue per year with its product set across EMEA, North America, Latin America and/or Asia-Pacific.
OneStream is helping a growing list of companies worldwide digitally transform finance and support strategic business decisions across the enterprise. OneStream customers are able to replace multiple legacy applications with OneStream’s unified Intelligent Finance platform and streamline key finance processes. Valued at more than $1B in 2019 and backed by global investment firm KKR, OneStream recently announced 2020 results and is well poised for a strong 2021.
To download the full report, click here .
About OneStream Software
OneStream Software provides a market-leading intelligent finance platform that reduces the complexity of financial operations. OneStream unleashes the power of finance by unifying corporate performance management (CPM) processes such as planning, financial close & consolidation, reporting and analytics through a single, extensible solution. We empower the enterprise with financial and operational insights to support faster and more informed decision-making. All in a cloud platform designed to continually evolve and scale with your organization.
OneStream is an independent software company backed by private equity investor KKR. With over 600 customers, 200 partners and over 700 employees our primary mission is to deliver 100% customer success. To learn more visit www.onestreamsoftware.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210329005071/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom